Edward Morrow Atkinson's most recent trade in 89bio Inc was a trade of 56,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 89bio Inc | Edward Morrow Atkinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 56,400 | 56,400 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Morrow Atkinson Edward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 45,150 | 45,150 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Edward Morrow Atkinson | Director | Sale of securities on an exchange or to another person at price $ 17.91 per share. | 01 Jun 2023 | 6,250 | 0 (0%) | 0% | 17.9 | 111,938 | Common Stock |
| 89bio Inc | Edward Morrow Atkinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 6,250 | 0 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Edward Morrow Atkinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.61 per share. | 01 Jun 2023 | 6,250 | 6,250 (0%) | 0% | 2.6 | 16,313 | Common Stock |
| 89bio Inc | Edward Morrow Atkinson | Director | Sale of securities on an exchange or to another person at price $ 13.60 per share. | 01 Mar 2023 | 10,000 | 0 (0%) | 0% | 13.6 | 136,000 | Common Stock |
| 89bio Inc | Edward Morrow Atkinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.44 per share. | 01 Mar 2023 | 10,000 | 10,000 (0%) | 0% | 4.4 | 44,400 | Common Stock |
| 89bio Inc | Edward Morrow Atkinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 10,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Edward Morrow Atkinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 27,400 | 27,400 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Edward Morrow Atkinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 6,250 | 6,250 | - | - | Stock Option (Right to Buy) |